|
2016 Conference Publication Cardiovascular Biomarkers, Global Left Ventricular Strain, and Tolerability of the Beta-Blocker Carvedilol in Patients Receiving DialysisRoberts, M., Badve, S., Carroll, R., Darssan, D., Fahim, M., Hawley, C., Isbel, N., Marshall, M., Pascoe, E., Pedagogos, E., Pilmore, H., Snelling, P., Tan, K., Tonkin, A., Vergara, L. and Ierino, F. (2016). Cardiovascular Biomarkers, Global Left Ventricular Strain, and Tolerability of the Beta-Blocker Carvedilol in Patients Receiving Dialysis. The 15th Asian Pacific Congress of Nephrology (APCN) and 52nd ANZSN ASM, Perth, WA, Australia, 17–21 September 2016. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. |
|
2016 Book Chapter Complications of peritoneal dialysisKennard, Alice, Johnson, David W. and Hawley, Carmel M. (2016). Complications of peritoneal dialysis. Core concepts in dialysis and continuous therapies. (pp. 121-133) edited by Colm C. Magee, J. Kevin Tucker and Ajay K. Singh. Boston, MA, United States: Springer. doi: 10.1007/978-1-4899-7657-4_10 |
|
2016 Journal Article The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: sub-study of the HERO trial.Zhang, Lei, Coombes, Jeff, Pascoe, Elaine M., Badve, Sunil V., Dalziel, Kim, Cass, Alan, Clarke, Philip, FerrarI, Paolo, McDonald, Stephen P., Morrish, Alicia T., Pedagogos, Eugenie, Perkovic, Vlado, Reidlinger, Donna, Scaria, Anish, Walker, Rowan, Vergara, Liza A., Hawley, Carmel M. and Johnson, David W. (2016). The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: sub-study of the HERO trial.. Redox Report, 21 (1), 14-23. doi: 10.1179/1351000215Y.0000000022 |
|
2016 Conference Publication Effect of the Beta-Blocker Carvedilol On Biomarkers of Cardiovascular Disease in Patients Receiving DialysisRoberts, M., Badve, S., Carroll, R., Darssan, D., Fahim, M., Hawley, C., Isbel, N., Marshall, M., Pascoe, E., Pedagogos, E., Pilmore, H., Snelling, P., Tan, K., Tonkin, A., Vergara, L. and Ierino, F. (2016). Effect of the Beta-Blocker Carvedilol On Biomarkers of Cardiovascular Disease in Patients Receiving Dialysis. The 15th Asian Pacific Congress of Nephrology (APCN) and 52nd ANZSN ASM, Perth, WA Australia, 17–21 September 2016. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. |
|
2016 Conference Publication Effect of fish oil and aspirin on arteriovenous fistula failure in haemodialysis - a randomized controlled trialIrish, A., Viecelli, A., Hawley, C., Hooi, L., Pascoe, E., Paul-Brent, P., Badve, S., Mori, T., Cass, A., Kerr, P., Voss, D., Ong, L. and Polkinghorne, K. (2016). Effect of fish oil and aspirin on arteriovenous fistula failure in haemodialysis - a randomized controlled trial. The 15th Asian Pacific Congress of Nephrology (APCN) and 52nd ANZSN ASM, Perth, WA, Australia, 17–21 September 2016. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12884 |
|
2016 Conference Publication Association of Socio-Economic Position with Technique Failure and Mortality in Australian Non-Indigenous Peritoneal Dialysis PatientsChan, S., Cho, Y., Koh, Y., Boudville, N., Mcdonald, S., Clayton, P., Pascoe, E., Francis, R., Mudge, D., Hawley, C. and Johnson, D. (2016). Association of Socio-Economic Position with Technique Failure and Mortality in Australian Non-Indigenous Peritoneal Dialysis Patients. The 15th Asian Pacific Congress of Nephrology (APCN) and 52nd ANZSN ASM, Perth, WA Australia, 17–21 September 2016. Richmond, VIC Australia: Wiley-Blackwell. |
|
2016 Conference Publication Inflammation in DialysisDheda, S., Min, H., Van, Eps C., Johnson, D., Vesey, D., Healy, H., Hawley, C. and Fahim, M. (2016). Inflammation in Dialysis. The 15th Asian Pacific Congress of Nephrology (APCN) and 52nd ANZSN ASM, Perth, Western Australia, 17–21 September 2016. Hoboken, NJ United States: Wiley-Blackwell. doi: 10.1111/nep.12887 |
|
2015 Journal Article The β-Blocker to lower cardiovascular dialysis events (BLOCADE) feasibility study: a randomized controlled trialRoberts, Matthew A., Pilmore, Helen L., Ierino, Francesco L., Badve, Sunil V., Cass, Alan, Garg, Amit X., Isbel, Nicole M., Krum, Henry, Pascoe, Elaine M., Perkovic, Vlado, Scaria, Anish, Tonkin, Andrew M., Vergara, Liza A., Hawley, Carmel M., BLOCADE Study Collaborative Group, Reidlinger, Donna, Tan, Ken-Soon and Martin, Andrew (2015). The β-Blocker to lower cardiovascular dialysis events (BLOCADE) feasibility study: a randomized controlled trial. American Journal of Kidney Diseases, 67 (6), 902-911. doi: 10.1053/j.ajkd.2015.10.029 |
|
2015 Journal Article The effect of exit-site antibacterial honey versus nasal mupirocin prophylaxis on the microbiology and outcomes of peritoneal dialysis-associated peritonitis and exit-site infections: a sub-study of the honeypot trialZhang, Lei, Badve, Sunil V., Pascoe, Elaine M., Beller, Elaine, Cass, Alan, Clark, Carolyn, de Zoysa, Janak, Isbel, Nicole M., McTaggart, Steven, Morrish, Alicia T., Playford, E. Geoffrey, Scaria, Anish, Snelling, Paul, Vergara, Liza A., Hawley, Carmel M. and Johnson, David W. (2015). The effect of exit-site antibacterial honey versus nasal mupirocin prophylaxis on the microbiology and outcomes of peritoneal dialysis-associated peritonitis and exit-site infections: a sub-study of the honeypot trial. Peritoneal Dialysis International, 35 (7), 712-721. doi: 10.3747/pdi.2014.00206 |
|
2015 Journal Article Biological variation of high sensitivity cardiac troponin-T in stable dialysis patients: Implications for clinical practiceFahim, Magid A., Hayen, Andrew D., Horvath, Andrea R., Dimeski, Goce, Coburn, Amanda, Tan, Ken-Soon, Johnson, David W., Craig, Jonathan C., Campbell, Scott B. and Hawley, Carmel M. (2015). Biological variation of high sensitivity cardiac troponin-T in stable dialysis patients: Implications for clinical practice. Clinical Chemistry and Laboratory Medicine, 54 (5), e149-e150. doi: 10.1515/cclm-2015-0998 |
|
2015 Journal Article Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohortMallett, A., Hughes, P., Szer, J., Tuckfield, A., Van Eps, C., Cambell, S. B., Hawley, C., Burke, J., Kausman, J., Hewitt, I., Parnham, A., Ford, S. and Isbel, N. (2015). Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohort. Internal Medicine Journal, 45 (10), 1054-1065. doi: 10.1111/imj.12864 |
|
2015 Journal Article Cessation of immunosuppression during chemotherapy for post-transplant lymphoproliferative disorders in renal transplant patientsTaylor, Emma, Jones, Mark, Hourigan, Matthew J., Johnson, David W., Gill, Devinder S., Isbel, Nicole, Hawley, Carmel M., Marlton, Paula, Gandhi, Maher K., Campbell, Scott B. and Mollee, Peter (2015). Cessation of immunosuppression during chemotherapy for post-transplant lymphoproliferative disorders in renal transplant patients. Nephrology Dialysis Transplantation, 30 (10), 1774-1779. doi: 10.1093/ndt/gfv260 |
|
2015 Conference Publication Comparison of Freelite (TM) and N Latex serum free light chain assays in subjects with end stage renal disease on haemodialysisKennard, A., Hawley, C., Tate, J., Klingberg, S., Pretorius, C. and Mollee, P. (2015). Comparison of Freelite (TM) and N Latex serum free light chain assays in subjects with end stage renal disease on haemodialysis. 51st Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Canberra, ACT, Australia, 7-9 September 2015. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/nep.12543 |
|
2015 Journal Article Temporal Changes in Mortality Risk by Dialysis Modality in the Australian and New Zealand Dialysis PopulationMarshall, Mark R., Polkinghorne, Kevan R., Kerr, Peter G., Agar, John W.M., Hawley, Carmel M. and McDonald, Stephen P. (2015). Temporal Changes in Mortality Risk by Dialysis Modality in the Australian and New Zealand Dialysis Population. American Journal of Kidney Diseases, 66 (3), 489-498. doi: 10.1053/j.ajkd.2015.03.014 |
|
2015 Journal Article The impact of fibroblast growth factor-23 on the cardiovascular system in chronic kidney diseaseLee, Gavin, Krishnasamy, Rathika, Hawley, Carmel M. and Johnson, David W. (2015). The impact of fibroblast growth factor-23 on the cardiovascular system in chronic kidney disease. Expert Review of Endocrinology and Metabolism, 10 (6), 565-568. doi: 10.1586/17446651.2015.1079124 |
|
2015 Journal Article Standardised outcomes in nephrology - Haemodialysis (SONG-HD): Study protocol for establishing a core outcome set in haemodialysisTong, Allison, Manns, Braden, Hemmelgarn, Brenda, Wheeler, David C., Tugwell, Peter, Winkelmayer, Wolfgang C., van Biesen, Wim, Crowe, Sally, Kerr, Peter G., Polkinghorne, Kevan R., Howard, Kirsten, Pollock, Carol, Hawley, Carmel M., Johnson, David W., McDonald, Stephen P., Gallagher, Martin P., Urquhart-Secord, Rachel and Craig, Jonathan C. (2015). Standardised outcomes in nephrology - Haemodialysis (SONG-HD): Study protocol for establishing a core outcome set in haemodialysis. Trials, 16 (364) 364, 464-475. doi: 10.1186/s13063-015-0895-7 |
|
2015 Journal Article Association between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: a secondary analysis of the HERO trialBadve, Sunil V., Zhang, Lei, Coombes, Jeff S., Pascoe, Elaine M., Cass, Alan, Clarke, Philip, Ferrari, Paolo, McDonald, Stephen P., Alicia T. Morrish, Eugenie Pedagogos, Vlado Perkovic, Donna Reidlinger, Anish Scaria, Rowan Walker, Liza A. Vergara, Carmel M. Hawley, David W. Johnson and and on behalf of the HERO Study Collaborative Group (2015). Association between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial. Canadian Journal of Kidney Health and Disease, 2 (33) 33, 1-10. doi: 10.1186/s40697-015-0066-5 |
|
2015 Journal Article An incident cohort study comparing survival on home hemodialysis and peritoneal dialysis (Australia and New Zealand Dialysis and Transplantation Registry)Nadeau-Fredette, Annie-Claire, Hawley, Carmel M., Pascoe, Elaine M., Chan, Christopher T., Clayton, Philip A., Polkinghorne, Kevan R., Boudville, Neil, Leblanc, Martine and Johnson, David W. (2015). An incident cohort study comparing survival on home hemodialysis and peritoneal dialysis (Australia and New Zealand Dialysis and Transplantation Registry). Clinical Journal of the American Society of Nephrology, 10 (8), 1397-1407. doi: 10.2215/CJN.00840115 |
|
2015 Journal Article Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney diseaseLo, Clement, Toyama, Tadashi, Hirakawa, Yoichiro, Jun, Min, Cass, Alan, Hawley, Carmel, Pilmore, Helen, Badve, Sunil V., Perkovic, Vlado and Zoungas, Sophia (2015). Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease. Cochrane Database of Systematic Reviews, 2015 (8) CD011798. doi: 10.1002/14651858.CD011798 |
|
2015 Journal Article Research Priorities in CKD: Report of a National Workshop Conducted in AustraliaTong, Allison, Crowe, Sally, Chando, Shingisai, Cass, Alan, Chadban, Steve J, Chapman, Jeremy R, Gallagher, Martin, Hawley, Carmel M, Hill, Sophie, Howard, Kirsten, Johnson, David W, Kerr, Peter G, McKenzie, Anne, Parker, David, Perkovic, Vlado, Polkinghorne, Kevan R, Pollock, Carol, Strippoli, Giovanni F.M, Tugwell, Peter, Walker, Rowan G, Webster, Angela C, Wong, Germaine and Craig, Jonathan C (2015). Research Priorities in CKD: Report of a National Workshop Conducted in Australia. American Journal of Kidney Diseases, 66 (2), 212-222. doi: 10.1053/j.ajkd.2015.02.341 |
